Clinical Trial Update: Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating adding bacteriophages to standard antibiotics for the treatment of infective endocarditis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infective Endocarditis

Drugs mentioned

• Bacteriophages (phage therapy) (phage therapy)

Snippet

Sponsor: University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) | Conditions: Endocarditis, Bacterial | Phase 3 | Status: RECRUITING